+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sciatica Market, by Disease Type, by Drug Class, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 237 Pages
  • August 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5417334
Sciatica refers to pain that radiates along the path of the sciatic nerve, which passes from lower back through hips to buttocks and down each leg. Typically, sciatica affects only one side of the body. This is often a chronic condition that is managed through the use of analgesics to control the pain and non-steroidal anti-inflammatory drugs (NSAIDS) to decrease inflammation. Sciatica is differentiated depending upon the severity of the pain faced by individuals such as acute sciatica, chronic sciatica, and others.



Acute sciatic is known as recent onset of pain in sciatic nerve for duration of four to eight weeks and pain can be self-managed by individuals through pain medications. In chronic sciatica, symptoms include persistent sciatic nerve pain, which lasts over eight weeks in individuals. There are two other types of sciatica which include alternating sciatica and bilateral sciatica. Alternating sciatica is a condition in which the sciatic nerve pain affects in both the legs alternately and thus may lead to degenerative problems in the sacroiliac joint. Bilateral sciatica is a condition in which the sciatic nerve pain occurs in both the legs together, this type of sciatic is very rare and may occur due to degenerative changes in the vertebrae and/or the disc at several spinal levels.

Market Dynamics


Increasing prevalence of sciatica is anticipated to drive the growth of global sciatica market over the forecast period. For instance, according to the article published in the Spine Health in December 2019, sciatica is common condition with a lifetime incidence varying from 10% to 40% of the population in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global sciatica market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sciatica market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC., Mylan N.V., Horizon Therapeutics Plc., Sun Pharmaceutical Industries Ltd., Alkem Labs, SCILEX Pharmaceuticals, Inc., Seikagaku Corporation, Kolon Life Science, Inc., Teijin Limited, and SpineThera, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global sciatica market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sciatica market

Detailed Segmentation:


Global Sciatica Market, By Disease Type:

  • Acute Sciatica
  • Chronic Sciatica
  • Others

Global Sciatica Market, By Drug Class:

  • Nonsteroidal Anti-Inflammatory Drugs
  • Oral Steroids
  • Anticonvulsant Agents
  • Tricyclic Antidepressants
  • Opioid Analgesics
  • Others

Global Sciatica Market, By Route of Administration:

  • Oral
  • Injectable

Global Sciatica Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Sciatica Market, By Region:

  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Region/Country
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Sorrento Therapeutics, Inc.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Zydus Cadila
  • Glenmark Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals LLC
  • Jubilant Life Sciences Ltd.
  • Hikma Pharmaceuticals PLC.
  • Mylan N.V.
  • Horizon Therapeutics Plc.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Labs
  • SCILEX Pharmaceuticals, Inc.
  • Seikagaku Corporation
  • Kolon Life Science, Inc.
  • Teijin Limited
  • SpineThera, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Frequently Asked Questions about the Sciatica Market

What is the estimated value of the Sciatica Market?

The Sciatica Market was estimated to be valued at $6302.9 Million in 2021.

What is the growth rate of the Sciatica Market?

The growth rate of the Sciatica Market is 4.8%, with an estimated value of $8776.2 Million by 2028.

What is the forecasted size of the Sciatica Market?

The Sciatica Market is estimated to be worth $8776.2 Million by 2028.

Who are the key companies in the Sciatica Market?

Key companies in the Sciatica Market include Sorrento Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Amneal Pharmaceuticals LLC, Jubilant Life Sciences Ltd., Hikma Pharmaceuticals PLC. and Horizon Therapeutics Plc..

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Sciatica Market Insights
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Merger, Acquisition & Agreements
  • Pipeline Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • Market Trends
  • Recent Product Launch/Approvals
  • Treatment Algorithm
  • PEST Analysis
  • Epidemiology Based Model for Sciatica

4. Global Sciatica Market-Impact of COVID-19
  • Economic Impact
  • Epidemiology
  • Impact on Drug Development and Clinical Trials

5. Global Sciatica Market, By Disease Type, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Acute Sciatica
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Chronic Sciatica
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

6. Global Sciatica Market, By Drug Class, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Nonsteroidal Anti-Inflammatory Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Oral Steroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Anticonvulsant Agents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Tricyclic Antidepressants
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Opioid Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Sciatica Market, By Route of Administration, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

8. Global Sciatica Market, By Distribution Channel, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028, (US$ Million)

9. Global Sciatica Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Region/Country, 2017-2028, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

10. Competitive Snapshot
Company Profiles
  • Sorrento Therapeutics, Inc.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Aurobindo Pharma Ltd.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Zydus Cadila
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Glenmark Pharmaceuticals Ltd.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Amneal Pharmaceuticals LLC
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Jubilant Life Sciences Ltd.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Hikma Pharmaceuticals PLC
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Mylan N.V.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Horizon Therapeutics Plc
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Alkem Labs
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • SCILEX Pharmaceuticals, Inc
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Seikagaku Corporation
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Kolon Life Science, Inc.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Teijin Limited
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • SpineThera, Inc.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies

11. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Sorrento Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Aurobindo Pharma Ltd.
  • Zydus Cadila
  • Glenmark Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals LLC
  • Jubilant Life Sciences Ltd.
  • Hikma Pharmaceuticals PLC.
  • Mylan N.V.
  • Horizon Therapeutics Plc.
  • Sun Pharmaceutical Industries Ltd.
  • Alkem Labs
  • SCILEX Pharmaceuticals, Inc.
  • Seikagaku Corporation
  • Kolon Life Science, Inc.
  • Teijin Limited
  • SpineThera, Inc.